(Q41756613)

8 October 2017

1 reference

title

Economic comparisons of the pharmacotherapy of depression: an overview (English)

1 reference

8 October 2017

0 references

Crott R

1

1 reference

8 October 2017

Gilis P

series ordinal

2

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

Acta Psychiatrica Scandinavica

8 October 2017

published in

1 reference

8 October 2017

volume

97

1 reference

8 October 2017

issue

4

1 reference

8 October 2017

page(s)

241-252

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

Utilization of health and mental health services. Three Epidemiologic Catchment Area sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

Factors affecting service utilization for depression in a white collar population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

Factors affecting help-seeking during depression in a community sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

Cost offset from a psychiatric consultation-liaison intervention with elderly hip fracture patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

Depression in Elderly Hospitalized Patients With Medical Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

Epidemiologic considerations in electroconvulsive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

Health care costs associated with depressive and anxiety disorders in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

Treatments of depression and the functional capacity to work.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

Disability and depression among high utilizers of health care. A longitudinal analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

The economic costs of mental illness in Sweden 1975.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

The economic burden of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

The course, morbidity, and costs of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

A model to evaluate the cost-effectiveness of oral therapies in the management of patients with major depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

Cost-effectiveness comparisons using "real world" randomized trials: the case of new antidepressant drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

Antidepressant efficacy and quality of life in depression: a double-blind study with moclobemide and fluoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

Cost utility analysis of maintenance treatment for recurrent depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

Cost-benefit analysis of prospective pharmacokinetic dosing of nortriptyline in depressed inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

Cost-benefit analysis of an educational program for general practitioners by the Swedish Committee for the Prevention and Treatment of Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

Service utilization and social morbidity associated with depressive symptoms in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB09995.X

10.1111/J.1600-0447.1998.TB09995.X

21 January 2018

Identifiers

DOI

1 reference

8 October 2017

1 reference